""
UC Davis Medicine - Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" New Park Honoring Cancer Survivors Opens ""
""

""
"" Increase in Autism Cases is Real, Report Finds ""
""

""
  Breastfeeding Boosts Baby's Resistance to Respiratory Illnesses  
""

""
  Grant Supports Rural Areas in Helping Children with Autism  
""

""
  Study Shows Syringe-Exchange Reduces HIV Risk Behavior  
""

""
  Consumers: UC Davis Medical Center has Highest Quality in Sacramento  
     
  Handgun Study to Fortify Crime Prevention Efforts  
     
  UC Medical Center Ranks Among Country's Top 50 Hospitals  
     
  Unique Program Aims to Get Pediatricians into Communities  
     
  New Predictor of Heart Disease Risk Causes Vessel Damage, Plaque Formation  
     
  Center for Perinatal Medicine and Law Established  
     
  UC Davis Study Identifies Promising Epilepsy Treatment  
     
  UC Davis Study Finds Eye Drops Delay Onset of Glaucoma  
     
  M.I.N.D. Institute Seeks Diagnostic Test for Autism  
     
  New Chair of Microbiology, Immunology Named  
     
  Career Satisfaction Varies by Specialty, Geographic Region  
     
  New Chair of Biological Chemistry Appointed  
Vertical Seperator Line
Summer 2003 Issue
""
NEWS
"" ""
""
"" ""
"" ""
 
""

UC DAVIS STUDY IDENTIFIES PROMISING EPILEPSY TREATMENT
 "" PHOTO
"" ""

Physicians at UC Davis Medical Center have identified a promising new treatment for epilepsy that reduces the number of seizures while helping patients lead more productive lives.

The study is the first to show that Levetiracetam (LEV), an antiepileptic drug typically used in combination with other drugs, might be successful as a single drug. The results were published in the October issue of Epilepsy and Behavior and presented at the American Epilepsy Association conference in Seattle in December.

"We found that LEV can be effective as a single drug, or monotherapy, in patients with newly diagnosed epilepsy, as well as in patients with difficult-to-control seizures," said Taoufik M. Alsaadi, assistant professor of neurology and co-director of the UC Davis Comprehensive Epilepsy Program.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite1200
Sacramento, California 95820

ucdavismedicine@ucdmc.ucdavis.edu

© 2003 UC Regents. All rights reserved.

"" "" ""